 |

Glycolytic Defects

Myophosphorylase Deficiency

Phosphofructokinase Deficiency

Phosphoglycerate Mutase

Phosphoglycerate Kinase

Lactate Dehydrogenase

Debrancher

Phosphorylase Kinase

Acid Maltase

Brancher

Glycogen NOS
|
 |
 |
 |
Myophosphorylase Deficiency
(glycogenosis type V; McArdle's Disease)
source: Ronald G. Haller, MD
McArdle's patients experience lifelong premature exertional
fatigue and are subject to exertional muscle pain, contractures,
and rhabdomyolysis when muscle energy demands exceed supply.
Later in life, McArdle's patients may develop fixed weakness.
The main goals for managing patients with McArdle's disease
are to improve exercise tolerance and to reduce the frequency
and severity of muscle injury. Success hinges on efforts
to avoid patterns of activity that require glycogen as an
energy source and to promote the utilization of preserved
energy pathways - especially lipid oxidation - to meet muscle
energy needs. Glycogen has anaerobic and oxidative functions.
Anaerobic glycogenolysis can support rates of energy turnover
more than twice that achieved by oxidative metabolism, and
it is necessary to fuel intense exercise and when oxygen
delivery is blocked. No substitute for anaerobic glycogenolysis
exists. To avoid muscle injury, it is therefore necessary
for patients to avoid ischemic or isometric exercise such
as heavy lifting and arm wrestling.
Glycogen also fuels pyruvate-dependent oxidative metabolism,
and glycogen unavailability makes muscle dependent on the
availability of blood-borne oxidative fuels. This is exemplified
by the second wind phenomenon, in which exercise tolerance
improves and the rate of muscle oxidative phosphorylation
is augmented when the availability of blood-borne oxidative
substrate (particularly free fatty acids and glucose) to muscle
is increased. The mobilization, delivery, and cellular transport
of blood-borne substrates are sluggish in comparison with
the availability of glycogen-derived pyruvate, so the oxidative
energy deficit is apparent in the transition from rest to
exercise. Also, maximal rates of oxidative phosphorylation
able to be achieved by blood-borne fuels are low compared
with that achieved with pyruvate. Warming up before engaging
in any sustained activity improves substrate availability
by increasing muscle blood flow and facilitating substrate
mobilization.
A diet rich in protein and adequate in carbohydrate is recommended
for McArdle's disease. Protein requirements are increased
by the ongoing muscle injury and increased muscle regeneration
that are typical of this condition. Also, amino acids provide
a potential alternative oxidative fuel for skeletal muscle.
When combined with a program of regular exercise, a high-protein
diet was found to improve exercise capacity significantly.
Dietary carbohydrate sufficient to maintain hepatic glycogen
stores is desirable, because glucose utilization and hepatic
glycogenolysis are increased during exercise in McArdle's
disease. The immediate effect of a carbohydrate meal may be
to reduce exercise capacity, owing to homeostatic mechanisms
that maintain blood glucose in a narrow range and the corresponding
reduction in plasma fatty acids levels. Intravenous glucose
raises blood glucose levels, increases glucose transport into
muscle, and augments exercise capacity, but it is useful primarily
in a hospital. Glucagon increases hepatic glycogenolysis and
may improve exercise capacity in the short term, but indications
for chronic treatment are unproven.
Long-chain free fatty acids (FFAs) represent the dominant
available oxidative fuel in glycolytic defects, but a high-fat
diet has not provided consistent benefits. Epinephrine increases
exercise capacity by augmenting lipolysis and increasing muscle
blood flow. A medium-chain triglyceride (MCT) diet increases
medium-chain fatty acids, which are preferentially oxidized
in liver to ketones, which can be oxidized by skeletal muscle.
MCT oil supplements may improve exercise tolerance, but some
patients experience nausea, diarrhea, and meager improvement
in exercise capacity, if any.
Regular aerobic exercise, by promoting mitochondrial biogenesis
and increasing the activity of rate-limiting oxidative enzymes,
increases fat oxidation and reduces the requirement for carbohydrate
utilization to supply muscle energy needs. Conditioning exercise
must be undertaken with caution, as overexertion may precipitate
muscle injury. We prescribe "low-level" exercise
(approximately 50 percent of maximal) performed for 20-40
minutes, three to four times per week. Because exercise intolerance
often varies in the course of a given exercise session owing
to patterns of substrate mobilization, exercise intensity
should be varied accordingly. Heart rate is a good objective
index of relative exercise intensity that the patient can
monitor with a pulsemeter (preferably) or by timing the pulse.
Serum CK should be monitored to ensure that the exercise program
is not producing increased muscle injury.
The most devastating acute consequence of McArdle's disease
is massive exertional muscle injury with myoglobinuria. It
is crucial to recognize muscle injury that is sufficient to
cause myoglobinuria, so that appropriate treatment can be
instituted. The major long-term consequence of McArdle's disease
is muscle weakness. A likely mechanism is recurrent muscle
injury, which ultimately exceeds the regenerative capacity
of skeletal muscle. Muscle magnetic resonance imaging sensitively
identifies focal muscle injury and decreased mass. For patients
with focal muscle atrophy, special attention should be given
to eliminating patterns of exercise that promote muscle injury;
to measures to augment substrate availability and improve
the capacity to oxidize available substrates; and to providing
adequate dietary protein to promote protein synthesis.
|
 |